erivedge-ppp.com.mt
HCP Pregnancy Prevention Programme Web Portal
The material is provided by Roche Products Ltd as a license requirement for this medicine and forms part of the Risk Management Plan
This medicinal product is subject to additional monitoring.
Reporting suspected adverse reactions after authorisation of a medicinal product is important.
It allows the continued monitoring of the benefit/risk balance of the medicinal product.